Estrella Immunopharma (ESLA) Cash & Equivalents (2021 - 2026)
Estrella Immunopharma (ESLA) recorded Cash & Equivalents of $146,670 in Q2 2026, down 92.4% from the prior quarter.
Powered by 
Analysis
Estrella Immunopharma (ESLA) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Estrella Immunopharma reported Cash & Equivalents of $1.38 million, up 51.0% from FY2024.
- Annual Cash & Equivalents has a four-year compound annual growth rate of 30.4% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $916,916 in FY2024, $2.48 million in FY2023, $40,802 in FY2022 (-91.5%) and $478,868 in FY2021.
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q1 2023.
- Per Business Quant, the preceding three quarters came in at $1.93 million (Q1 2026), $1.38 million (Q4 2025) and $1.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Estrella Immunopharma | 20.44 Mn | 15.36 Mn | - | 146,670.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 146,670.00 |
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 421,473.00 |
| Dec 31, 2024 | 916,916.00 |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Dec 31, 2023 | 9.05 Mn |
| Sep 30, 2023 | 22.14 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 29,390.00 |
| Dec 31, 2022 | 40,802.00 |
| Sep 30, 2022 | 73,752.00 |
| Jun 30, 2022 | 88,281.00 |
| Mar 31, 2022 | 321,724.00 |
| Dec 31, 2021 | 478,868.00 |
| Sep 30, 2021 | 321,724.00 |
API Access
Estrella Immunopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ESLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ESLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ESLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();